Summary
The Defense Health Agency (Healthcare Contracting Division - West) intends to award a sole-source, firm-fixed-price contract for comprehensive newborn bloodspot screening services supporting five Military Treatment Facilities in Guam and Japan. The procurement covers testing for organic acidemias, fatty acid oxidation disorders, amino acid disorders, endocrine disorders, and lysosomal storage diseases and cites FAR 13.501 as the basis for the sole-source determination. The notice was posted 2026-01-15 with a response deadline of 2026-01-30 and identifies Oregon Health Authority as the intended sole source vendor.